Metraipolis › archive › dc_bbb7fcc3dee3

Neoadjuvant immunotherapy for lung cancer: current limitations and future prospects — Europe PMC PMID:41685302

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41685302
DOI: 10.3389/fimmu.2026.1752298
License (as archived): solo-consultazione
Archived: 2026-11-06T11:39:44.912Z
SHA-256 of the archived text: e8d6f750b9e64c90225ebed512837911f8d360f253bd04862c41d938e4d840f7
Stable URL of this page: https://metraipolis.com/documento/dc_bbb7fcc3dee3

How to cite

Neoadjuvant immunotherapy for lung cancer: current limitations and future prospects — Europe PMC PMID:41685302 — Europe PMC (en), https://europepmc.org/article/MED/41685302 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbb7fcc3dee3 (Metraipolis archive dc_bbb7fcc3dee3, sha256 e8d6f750b9e64c90225ebed512837911f8d360f253bd04862c41d938e4d840f7)

BibTeX

@misc{dcbbb7fcc3dee3,
  title = {Neoadjuvant immunotherapy for lung cancer: current limitations and future prospects — Europe PMC PMID:41685302},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41685302},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbb7fcc3dee3; sha256 e8d6f750b9e64c90225ebed512837911f8d360f253bd04862c41d938e4d840f7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41685302. Agents can read the archived copy with the MCP tool read_document.